Article

Adenine Nucleotide Translocase 1 Deficiency Results in Dilated Cardiomyopathy With Defects in Myocardial Mechanics, Histopathological Alterations, and Activation of Apoptosis

Center for Mitochondrial and Molecular Medicine and Genetics (MAMMAG), University of California, Irvine, California, USA.
JACC. Cardiovascular imaging (Impact Factor: 14.29). 01/2011; 4(1):1-10. DOI: 10.1016/j.jcmg.2010.06.018
Source: PubMed

ABSTRACT the aim of this study was to test the hypothesis that chronic mitochondrial energy deficiency causes dilated cardiomyopathy, we characterized the hearts of age-matched young and old adenine nucleotide translocator (ANT)1 mutant and control mice.
ANTs export mitochondrial adenosine triphosphate into the cytosol and have a role in the regulation of the intrinsic apoptosis pathway. Mitochondrial energy deficiency has been hypothesized, on the basis of indirect evidence, to be a factor in the pathophysiology of dilated cardiomyopathies. Ant1 inactivation should limit adenosine triphosphate for contraction and calcium transport, thereby resulting in early cardiac dysfunction with later dilation and heart failure.
we conducted a multiyear study of 73 mutant (Ant1-/-) and 57 control (Ant1+/+) mice, between the ages of 2 and 21 months. Hearts were characterized by cardiac anatomy, echocardiographic imaging with velocity vector analysis, histopathology, and apoptosis assays.
the Ant1-/- mice developed a distinctive concentric dilated cardiomyopathy, characterized by substantial myocardial hypertrophy and ventricular dilation, with cardiac function declining earlier in age as compared to control mice. Left ventricular circumferential, radial, and rotational mechanics were reduced even in the younger mutants with preserved systolic function. Histopathologic analysis demonstrated increased myocyte hypertrophy, fibrosis, and calcification in the mutant mice as compared with control mice. Furthermore, increased cytoplasmic cytochrome c levels and caspase 3 activation were observed in the mutant mice.
our results demonstrate that mitochondrial energy deficiency is sufficient to cause dilated cardiomyopathy, confirming that energy defects are a factor in this disease. Energy deficiency initially leads to early mechanical dysfunction before a decline in left ventricular systolic function. Chronic energy deficiency with age then leads to heart failure. Our results now allow us to use the Ant1-/- mouse model for testing new therapies for ANT1 mutant patients.

0 Bookmarks
 · 
101 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Inflammation contributes significantly to cardiac dysfunction. Although the initial phase of inflammation is essential for repair and healing, excessive pro-inflammatory cytokines are detrimental to the heart. We found that adenine nucleotide translocator isoform 1 (ANT1) protein levels were significantly decreased in the inflamed heart of C57BL/6 mice following Cecal Ligation and Puncture (CLP). To understand the molecular mechanisms involved, we performed siRNA-mediated knockdown of ANT1 and studied tumor necrosis factor alpha (TNFα)-induced inflammatory responses in myocardium-derived H9c2 cells and cardiomyocytes. ANT1 knockdown significantly increased swollen mitochondria and mitochondrial reactive oxygen species (mtROS), concomitant with increased TNFα-induced NF-κB reporter gene activity and interleukin-6 (IL-6) and TNFα expression. A mitochondrial-targeted antioxidant, mito-TEMPO (MTP), attenuated TNFα-induced mtROS, NF-κB reporter gene activity and cytokine expression in ANT1 knockdown cells. Interestingly, TNFα or lipopolysaccharide (LPS) treatment significantly decreased ANT1 protein levels, suggesting a feed-forward regulation of pro-inflammatory cytokine expression activated by ANT1 down-regulation. These data suggest that ANT1 down-regulation contributes to cardiac inflammation post CLP. Preventing ANT1 down-regulation could provide a novel molecular target to temper cardiac inflammation.
    AJP Heart and Circulatory Physiology 11/2014; 308(1):ajpheart.00330.2014. DOI:10.1152/ajpheart.00330.2014 · 4.01 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The mitochondrial phosphate carrier (PiC) is critical for ATP synthesis by serving as the primary means for mitochondrial phosphate import across the inner membrane. In addition to its role in energy production, PiC is hypothesized to have a role in cell death as either a component or a regulator of the mitochondrial permeability transition pore (MPTP) complex. Here, we have generated a mouse model with inducible and cardiac-specific deletion of the Slc25a3 gene (PiC protein). Loss of PiC protein did not prevent MPTP opening, suggesting it is not a direct pore-forming component of this complex. However, Slc25a3 deletion in the heart blunted MPTP opening in response to Ca(2+) challenge and led to a greater Ca(2+) uptake capacity. This desensitization of MPTP opening due to loss or reduction in PiC protein attenuated cardiac ischemic-reperfusion injury, as well as partially protected cells in culture from Ca(2+) overload induced death. Intriguingly, deletion of the Slc25a3 gene from the heart long-term resulted in profound hypertrophy with ventricular dilation and depressed cardiac function, all features that reflect the cardiomyopathy observed in humans with mutations in SLC25A3. Together, these results demonstrate that although the PiC is not a direct component of the MPTP, it can regulate its activity, suggesting a novel therapeutic target for reducing necrotic cell death. In addition, mice lacking Slc25a3 in the heart serve as a novel model of metabolic, mitochondrial-driven cardiomyopathy.Cell Death and Differentiation advance online publication, 21 March 2014; doi:10.1038/cdd.2014.36.
    Cell death and differentiation 03/2014; DOI:10.1038/cdd.2014.36 · 8.24 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A point mutation (stress-sensitive B(1), sesB(1) in the Drosophila gene coding for the major adult isoform of the adenine nuclear translocase (ANT) represents a model for human diseases associated with ANT insufficiency. We characterized the organismal, bioenergetic and molecular phenotype of sesB(1), then tested strategies to compensate the mutant phenotype. In addition to developmental delay and bang-sensitivity, sesB(1) manifests impaired response to sound, defective male courtship, female sterility and curtailed lifespan. These phenotypes, apart from the last two, are shared with the tko(25t) mutant in mitoribosomal protein S12. Mitochondria from sesB(1) adults showed a decreased respiratory control ratio and downregulation of cytochrome oxidase. sesB(1) adults exhibited ATP depletion, lactate accumulation, and changes in gene expression consistent with a metabolic shift towards glycolysis, with activation of lactate dehydrogenase and anaplerotic pathways. Females also showed downregulation of many genes required for oogenesis, and their eggs, though fertilized, failed to develop to the larval stages. The sesB(1) phenotypes of developmental delay and bang-sensitivity were alleviated by altered mtDNA background. Female sterility was substantially rescued by somatic expression of the alternative oxidase (AOX) from Ciona intestinalis, whereas AOX did not alleviate developmental delay. Our findings illustrate the potential of different therapeutic strategies for ANT-linked diseases, based on increasing mitochondrial bioenergy production, or on alleviating metabolic stress.
    Disease Models and Mechanisms 05/2014; DOI:10.1242/dmm.016527 · 4.96 Impact Factor

Full-text (2 Sources)

Download
20 Downloads
Available from
May 21, 2014